Home Financial Markets Here is why Brooklyn ImmunoTherapeutics Inc. (BTX) stock performed well on Friday...

Here is why Brooklyn ImmunoTherapeutics Inc. (BTX) stock performed well on Friday after plunging on Thursday?

Brooklyn ImmunoTherapeutics Inc. (BTX) stock flipped strongly on Friday, April 30, 2021, after poor performance on Thursday. The BTX stock gained 45.53% to close the normal Friday trading session at $49.80 per share. It continued its momentum and further jumped 32.55% in the after-hours trading on Friday.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

BTX shares have surged 2130.58% over the last 12 months, and they have moved up by 208.17% in the past week. Over the past three months, the stock has gained 538.46%, while over the past six months, it has added 1190.16%.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Let’s see how BTX stock turnaround from Thursday’s bad performance?

Exclusive License acquisition for the mRNA technology platform

On April 29, 2021, Brooklyn ImmunoTherapeutics said that it has acquired an exclusive license for mRNA gene editing and cell therapies technology.

The license will also provide to use an extensively patented process to develop gene-editing compounds using mRNA, which preclinical data suggest demonstrating a high degree of efficiency, as well as being non-immunogenic and non-mutagenic.

New appointment

On April 26, 2021, Brooklyn ImmunoTherapeuticsappointedMatthew During, M.D., Ph.D. to the Company’s Scientific Advisory Board, effective immediately.

Dr. During is a Harvard, MIT, and Yale-trained neuroscientist with vast working experience as a faculty member at different reputable universities.

Inducement Grants

On April 19, 2021, Brooklyn ImmunoTherapeuticsreported that the company granted a nonqualified stock option covering 2,627,915 shares of Brooklyn’s common stock to Dr. Federof.

Previously on 16 April 2021, Dr. Federoff was granted a nonqualified stock option covering 597,253 shares of Brooklyn’s common stock. This inducement grant is given to Dr. Federoff’s for his devoted continuous service with Brooklyn.

mRNA Technology Platform license Acquisition

On April 15, 2021, Brooklyn ImmunoTherapeuticspaid$1 million to acquire the Factor Bioscience’s and Novellus’ mRNA Gene Editing and Cell Therapies technology license which has been extended till May 21, 2021.

Upon completion, Brooklyn would be able to start a patented process to seek to develop gene-edited compounds using mRNA which are used for the treatment of several solid tumor and liquid indications, sickle cell anemia, as well as for several additional inherited disorders.

New Board member

On April 15, 2021, Brooklyn ImmunoTherapeutics appointed Dennis H. Langer, M.D., J.D. to the Company’s Board as an Independent Director, effective May 1, 2021.

New CEO appointment

On April 6, 2021, Brooklyn ImmunoTherapeutics appointed Howard J. Federoff, M.D., Ph.D., as Chief Executive Officer and President and a director as of 16 April 2021.

Ronald Guido was replaced by Dr. Federoff, who was serving as Interim CEO and will remain on Brooklyn’s management team as Chief Development Officer.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

BTX performed well because of the recent license acquisition news which came late on Thursday, after market closure. We can see it continue its positive momentum on Monday as well.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Relmada Therapeutics Inc. (RLMD) stock is plunging in the current trading session; What’s going on?

In the current trading session, Relmada Therapeutics Inc. (RLMD) stock shares are plunging by -5.97%. The current trading price is at $23.62 in the...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Related News

Relmada Therapeutics Inc. (RLMD) stock is plunging in the current trading session; What’s going on?

In the current trading session, Relmada Therapeutics Inc. (RLMD) stock shares are plunging by -5.97%. The current trading price is at $23.62 in the...

Helix Energy Solutions Inc. (HLX) stock fell during pre-market. What’s behind this decline?

Helix Energy Solutions Group Inc. (HLX) stock gained by 4.54% at the last close whereas the HLX stock price plunged by 6.72% in the...

Here is why Range Resources Corporation (RRC) stock plummeted in the after-hours on Monday?

Range Resources Corporation (RRC) shares lost 6.50% in after-hours on Monday, July 26, 2021, and close the daily trading at $14.95. in the regular...

ATI Physical Therapy Inc. (ATIP) stock declines during current market trading. Here’s the recent development.

ATI Physical Therapy Inc. (ATIP) stock plunged by 36.45% in the current market trading session. ATI is leading the market by creating quality standards...

Meten Edtechx Ltd. (METX) stock declines during pre-market trading given no current news

Meten Edtechx Ltd. (METX) stock plunged by 29.42% at the last close while the METX stock price fell by 8.64% in the pre-market trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam